Robert Boden
Professor vid Institutionen för medicinska vetenskaper; Psykiatri
- E-post:
- robert.boden@neuro.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 10
- Postadress:
- Akademiska sjukhuset, ingång 10, plan
751 85 UPPSALA
Ladda ned kontaktuppgifter för Robert Boden vid Institutionen för medicinska vetenskaper; Psykiatri
- Akademiska meriter:
- MD PhD
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Urval av publikationer
- Substance use disorders are risk factors for treatment resistant depression (2018)
- Treatment resistant depression as a risk factor for substance use disorders-A national register-based cohort study (2018)
- Humanistic outcomes in treatment resistant depression (2018)
- Persistent tachycardia in clozapine treated patients (2018)
- Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder (2018)
- Striatal Phosphodiesterase 10A and Medial Prefrontal Cortical Thickness in Patients with Schizophrenia (2017)
- Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia (2017)
- Suicide, Self-harm, and Depression After Gastric Bypass Surgery (2017)
- Tachycardia in Patients Treated with Clozapine versus Antipsychotic Long-Acting Injections (2017)
- Persistent Clozapine Associated Tachycardia Investigated with 24 Hour Ambulatory Electrocardiogram (2017)
- Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections (2017)
- Comparative risks of treatment failure in bipolar 1 disorder (2017)
- Reducing the rehospitalization risk after a manic episode (2017)
- Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting Injectable (2016)
- Risk factors for suicide among patients with schizophrenia (2016)
- Suicide risk and antipsychotic side effects in schizophrenia (2016)
- Theta burst transcranial magnetic stimulation of the dorsomedial prefrontal cortex in schizophrenia and depression (2015)
- Higher mortality after myocardial infarction in patients with severe mental illness (2015)
- Risk of Suicide, Self-Harm and Depression after Gastric Bypass (2015)
- Diabetes and glucose disturbances in patients with psychosis in Sweden (2015)
- Suicide Risk and Side Effects from Antipsychotics in Schizophrenia (2015)
- Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder-A nationwide cohort study (2015)
- Suicide in first episode psychosis (2014)
- Myocardial infarction survival in patients with bipolar disorder or schizophrenia spectrum disorders- a nationwide cohort study (2014)
- Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia (2014)
- Factors associated with pregabalin dispensing at higher than the approved maximum dose (2014)
- Medication and Risk of Rehospitalization in Bipolar Disorder (2014)
- Clinical Factors Associated with Prescription Filling of Mood-Stabilizers in Bipolar Disorder - A Population-Based Cohort Study (2014)
- Neuropeptide Y, social function and long-term outcome in schizophrenia (2014)
- Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment (2014)
- A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice (2013)
- Metabolic risk factors in first-episode schizophrenia (2013)
- Medication and suicide risk in schizophrenia (2013)
- Antipsychotic Prescription Filling in Patients With Schizophrenia or Schizoaffective Disorder (2013)
- Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder (2012)
- Antidopaminergic drugs and acute pancreatitis (2012)
- Electrocardiographic signs of autonomic imbalance in medicated patients with first-episode schizophrenia spectrum disorders (2012)
- Antipsychotics During Pregnancy Relation to Fetal and Maternal Metabolic Effects (2012)
- Antipsychotic Medication Adherence in Patients with Schizophrenia or Schizoaffective Disorder (2012)
- Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder (2011)
- Prognostic Factors in First-Episode Schizophrenia (2010)
- Five-year outcome of first-episode psychosis before and after the implementation of a modified assertive community treatment programme (2010)
Senaste publikationer
- Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode (2024)
- GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy (2024)
- Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode (2024)
- An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease (2024)
- Early symptom improvement and other clinical predictors of response to repetitive transcranial magnetic stimulation for depression (2024)
Alla publikationer
Artiklar
- Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode (2024)
- GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy (2024)
- Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode (2024)
- An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease (2024)
- Early symptom improvement and other clinical predictors of response to repetitive transcranial magnetic stimulation for depression (2024)
- No effects on heart rate variability in depression after treatment with dorsomedial prefrontal intermittent theta burst stimulation (2023)
- Psychometric properties of the Clinical Assessment Interview for Negative Symptoms (CAINS) in patients with depression and its relationship to affective symptoms (2023)
- Suppressing visual hallucinations in an adolescent by occipital transcranial magnetic stimulation (2023)
- The association between exposure to clozapine, olanzapine, and quetiapine and the outcomes perimyocarditis and heart failure (2023)
- Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression-A Swedish register-based study (2023)
- Macroscopic resting state model predicts theta burst stimulation response (2023)
- Response to electroconvulsive therapy in treatment-resistant depression (2023)
- Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy (2023)
- A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS) (2022)
- Application of positron emission tomography in psychiatry-methodological developments and future directions (2022)
- Modulation of dorsolateral prefrontal cortex functional connectivity after intermittent theta-burst stimulation in depression (2022)
- Ambulatory Heart Rate Variability in Schizophrenia or Depression (2021)
- Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression (2021)
- Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation (2021)
- Lithium influences whole-organism metabolic rate inDrosophila subobscura (2021)
- Inhibitory and excitatory neurotransmitter systems in depressed and healthy (2021)
- Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity (2021)
- Unchanged cognitive performance and concurrent prefrontal blood oxygenation after accelerated intermittent theta-burst stimulation in depression (2021)
- Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression (2021)
- Autonomic modulation networks in schizophrenia (2020)
- Substance use disorders and risk for treatment resistant depression (2020)
- Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures (2020)
- A register-based approach to identifying treatment-resistant depression (2020)
- Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depression (2020)
- Intermittent theta burst stimulation over the dorsomedial prefrontal cortex modulates resting-state connectivity in depressive patients (2020)
- Phosphodiesterase 10A levels are related to striatal function in schizophrenia (2020)
- Transcranial magnetic intermittent theta-burst stimulation for depression in pregnancy - A case series (2020)
- Risk of Delayed Discharge and Reoperation of Gastric Bypass Patients with Psychiatric Comorbidity (2020)
- Treatment-resistant depression as risk factor for substance use disorders (2019)
- Suicide Ideation and Behavior as Risk Factors for Subsequent Suicide in Schizophrenia (2019)
- All-cause mortality in patients with treatment-resistant depression (2019)
- A case of bipolar disorder onset with subsequent catatonia in a 14-year-old boy treated successfully with electroconvulsive therapy (2019)
- Monotherapy vs. combination therapy for post mania maintenance treatment (2019)
- Substance use disorders are risk factors for treatment resistant depression (2018)
- Treatment resistant depression as a risk factor for substance use disorders-A national register-based cohort study (2018)
- Humanistic outcomes in treatment resistant depression (2018)
- Persistent tachycardia in clozapine treated patients (2018)
- Mortality in treatment-resistant unipolar depression (2018)
- Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder (2018)
- Striatal Phosphodiesterase 10A and Medial Prefrontal Cortical Thickness in Patients with Schizophrenia (2017)
- Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia (2017)
- Suicide, Self-harm, and Depression After Gastric Bypass Surgery (2017)
- Tachycardia in Patients Treated with Clozapine versus Antipsychotic Long-Acting Injections (2017)
- Persistent Clozapine Associated Tachycardia Investigated with 24 Hour Ambulatory Electrocardiogram (2017)
- Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections (2017)
- Comparative risks of treatment failure in bipolar 1 disorder (2017)
- Reducing the rehospitalization risk after a manic episode (2017)
- Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting Injectable (2016)
- Striatal Phosphodiesterase 10A and Thinning of the medial Prefrontal Cortex in Schizophrenia - a PET and MRI study (2016)
- Risk factors for suicide among patients with schizophrenia (2016)
- Re (2016)
- Suicide risk and antipsychotic side effects in schizophrenia (2016)
- Higher mortality after myocardial infarction in patients with severe mental illness (2015)
- Risk of Suicide, Self-Harm and Depression after Gastric Bypass (2015)
- Diabetes and glucose disturbances in patients with psychosis in Sweden (2015)
- Suicide Risk and Side Effects from Antipsychotics in Schizophrenia (2015)
- Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder-A nationwide cohort study (2015)
- Suicide in first episode psychosis (2014)
- Myocardial infarction survival in patients with bipolar disorder or schizophrenia spectrum disorders- a nationwide cohort study (2014)
- Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia (2014)
- Factors associated with pregabalin dispensing at higher than the approved maximum dose (2014)
- Medication and Risk of Rehospitalization in Bipolar Disorder (2014)
- Clinical Factors Associated with Prescription Filling of Mood-Stabilizers in Bipolar Disorder - A Population-Based Cohort Study (2014)
- Neuropeptide Y, social function and long-term outcome in schizophrenia (2014)
- Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment (2014)
- A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice (2013)
- Metabolic risk factors in first-episode schizophrenia (2013)
- Medication and suicide risk in schizophrenia (2013)
- Antipsychotic Prescription Filling in Patients With Schizophrenia or Schizoaffective Disorder (2013)
- Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder (2012)
- Antidopaminergic drugs and acute pancreatitis (2012)
- Electrocardiographic signs of autonomic imbalance in medicated patients with first-episode schizophrenia spectrum disorders (2012)
- Antipsychotics During Pregnancy Relation to Fetal and Maternal Metabolic Effects (2012)
- Antipsychotic Medication Adherence in Patients with Schizophrenia or Schizoaffective Disorder (2012)
- Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder (2011)
- Five-year outcome of first-episode psychosis before and after the implementation of a modified assertive community treatment programme (2010)
- Biochemical risk factors for development of obesity in first-episode schizophrenia (2009)
- Association between symptomatic remission and functional outcome in first-episode schizophrenia (2009)
- Perimyocarditis and heart failure after exposure to clozapine, olanzapine, and quetiapine: A population-based cohort study
- Biological markers for CNS damage in a patient cohort with suspected autoimmune psychiatric disease
- Allopregnanolone and progesterone in relation to a single electroconvulsive therapy seizure and subsequent clinical outcome: an observational cohort study
- Motor cortex excitability in schizophrenia or depression and its modulation with prefrontal intermittent theta-burst stimulation
Böcker
Konferenser
